Skip to main content
. 2022 Dec 23;13:1015613. doi: 10.3389/fmicb.2022.1015613

Figure 6.

Figure 6

Antibacterial activity of biosynthesized selenium nanoparticles (BioSeNPs) suspensions (0.5–5.0 μg ml−1) fabricated by Bacillus subtilis AS12 against pathogenic Gram-positive bacteria (G+ bacteria) and Gram-negative bacteria (G− bacteria).